Stryker Corp (SYK) stock
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/306% below fair value
$317.54+6.82 (+2.19%)
Close on Nov 17, 2026Market cap $120.89BP/E 33.8Yield –
Stryker r&d expenses
Research and development expenses are spending on new products and technology.
Stryker's R&D Expenses for the twelve months ending Sep 30, 2026 was $1.68B, up 6.4% year over year. For fiscal 2025 it was $1.62B, up 10.7% from the year before. Over ten years it grew 10.0% a year on average. The highest annual figure on record is $1.62B in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.62B | +10.7% |
| FY2024 | Dec 31, 2024 | $1.47B | +5.6% |
| FY2023 | Dec 31, 2023 | $1.39B | -4.5% |
| FY2022 | Dec 31, 2022 | $1.45B | +17.7% |
| FY2021 | Dec 31, 2021 | $1.24B | +25.5% |
| FY2020 | Dec 31, 2020 | $984.00M | +1.3% |
| FY2019 | Dec 31, 2019 | $971.00M | +12.6% |
| FY2018 | Dec 31, 2018 | $862.00M | +9.5% |
| FY2017 | Dec 31, 2017 | $787.00M | +10.1% |
| FY2016 | Dec 31, 2016 | $715.00M | +14.4% |
| FY2015 | Dec 31, 2015 | $625.00M | +1.8% |
| FY2014 | Dec 31, 2014 | $614.00M | +14.6% |
| FY2013 | Dec 31, 2013 | $536.00M | +13.8% |
| FY2012 | Dec 31, 2012 | $471.00M | +1.9% |
| FY2011 | Dec 31, 2011 | $462.00M | +17.3% |
| FY2010 | Dec 31, 2010 | $394.00M | +17.3% |
| FY2009 | Dec 31, 2009 | $336.00M | -8.6% |
| FY2008 | Dec 31, 2008 | $367.80M | -2.0% |
| FY2007 | Dec 31, 2007 | $375.30M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $433.00M | +5.6% |
| Q2 FY2026 | Jun 30, 2026 | $434.00M | +6.6% |
| Q1 FY2026 | Mar 31, 2026 | $413.00M | +2.0% |
| Q4 FY2025 | Dec 31, 2025 | $401.00M | +12.0% |
| Q3 FY2025 | Sep 30, 2025 | $410.00M | +8.8% |
| Q2 FY2025 | Jun 30, 2025 | $407.00M | +12.1% |
| Q1 FY2025 | Mar 31, 2025 | $405.00M | +10.1% |
| Q4 FY2024 | Dec 31, 2024 | $358.00M | +2.3% |
| Q3 FY2024 | Sep 30, 2024 | $377.00M | +6.8% |
| Q2 FY2024 | Jun 30, 2024 | $363.00M | +4.9% |
| Q1 FY2024 | Mar 31, 2024 | $368.00M | +8.6% |
| Q4 FY2023 | Dec 31, 2023 | $350.00M | +7.4% |
| Q3 FY2023 | Sep 30, 2023 | $353.00M | -3.0% |
| Q2 FY2023 | Jun 30, 2023 | $346.00M | -1.4% |
| Q1 FY2023 | Mar 31, 2023 | $339.00M | -17.9% |
| Q4 FY2022 | Dec 31, 2022 | $326.00M | -1.5% |
| Q3 FY2022 | Sep 30, 2022 | $364.00M | +19.0% |
| Q2 FY2022 | Jun 30, 2022 | $351.00M | +13.2% |
| Q1 FY2022 | Mar 31, 2022 | $413.00M | +43.4% |
| Q4 FY2021 | Dec 31, 2021 | $331.00M | +29.8% |
| Q3 FY2021 | Sep 30, 2021 | $306.00M | +26.4% |
| Q2 FY2021 | Jun 30, 2021 | $310.00M | +33.0% |
| Q1 FY2021 | Mar 31, 2021 | $288.00M | +13.4% |
| Q4 FY2020 | Dec 31, 2020 | $255.00M | +0.4% |
| Q3 FY2020 | Sep 30, 2020 | $242.00M | -1.6% |
| Q2 FY2020 | Jun 30, 2020 | $233.00M | -5.3% |
| Q1 FY2020 | Mar 31, 2020 | $254.00M | +12.9% |
| Q4 FY2019 | Dec 31, 2019 | $254.00M | +14.9% |
| Q3 FY2019 | Sep 30, 2019 | $246.00M | +11.3% |
| Q2 FY2019 | Jun 30, 2019 | $246.00M | +13.9% |
| Q1 FY2019 | Mar 31, 2019 | $225.00M | +10.3% |
| Q4 FY2018 | Dec 31, 2018 | $221.00M | +7.8% |
| Q3 FY2018 | Sep 30, 2018 | $221.00M | +11.6% |
| Q2 FY2018 | Jun 30, 2018 | $216.00M | +12.5% |
| Q1 FY2018 | Mar 31, 2018 | $204.00M | +6.3% |
| Q4 FY2017 | Dec 31, 2017 | $205.00M | +8.5% |
| Q3 FY2017 | Sep 30, 2017 | $198.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $192.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $192.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $189.00M | – |
See a number that looks wrong?